Search Results 221-230 of 16996 for monoclonal antibody

  1. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  2. Infliximab-dyyb (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a monoclonal antibody that works on the immune system. This medicine is available only with your doctor's prescription. This product is ...

  3. Mayo Clinic Q&A podcast: Tackling the latest COVID-19 topics

    Antibody tests after having a COVID-19 vaccine. Monoclonal antibodies. COVID-19 variants. Side effects, especially after second COVID-19 vaccine ...

  4. Amyloidosis - Diagnosis and treatment - Mayo Clinic

    Most people start therapy that contains daratumumab (Darzalex), which is a monoclonal antibody used to treat multiple myeloma. ATTR therapies. Drugs such as ...

  5. Linvoseltamab-gcpt (intravenous route) - Side effects & uses - Mayo Clinic

    These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

  6. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  7. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  8. Mayo Clinic Study Suggests Two is Better Than One When Battling Agressive Lymphoma

    When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse ...

  9. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

    Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate (ADC) containing humanized anti- B-cell maturation antigen (BCMA) monoclonal antibody (mAb).

  10. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

    Primary mediastinal large B cell lymphoma is treated with a combination of chemotherapy and the monoclonal antibody rituximab (chemoimmunotherapy).